Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
B-cell lymphoma
Biotech
Oncternal reports patient death in CAR-T dose-escalation study
Oncternal reported the death of a patient in a trial following an elevated dose of its autologous CAR-T therapy aimed at aggressive B-cell lymphomas.
Conor Hale
Dec 28, 2023 10:52am
Cargo, undeterred by market challenges, seeks $281M IPO
Nov 10, 2023 10:00am
Caribou heads 'where the puck is going' with cell therapy plan
Jun 6, 2023 2:25pm
ASH: Should existing BTKs worry about Lilly's newcomer?
Dec 12, 2022 5:30pm
FDA lifts clinical hold on Curis' phase 1/2 lymphoma trial
Aug 18, 2022 11:23am
Schrödinger gears up for clinic, eyes 'hundreds' of programs
Jul 8, 2022 10:53am